Dr. Neerja Hajela

Dr. Neerja Hajela

Head of Science & Regulatory Affairs, Yakult Danone India Pvt. Ltd

Neerja Hajela is a distinguished nutrition expert and scientific leader with over two decades of experience at the intersection of microbiome science, gut health, regulatory affairs, and healthcare innovation. Currently serving as the Chief Scientific Officer – Science & Regulatory Affairs at Yakult Danone India, she is recognized for her significant contributions to advancing evidence-based understanding and responsible communication in the field of probiotics and gut health. Throughout her career, Neerja has focused on translating scientific evidence into credible, compliant, and impactful healthcare frameworks relevant to healthcare professionals, consumers, and industry stakeholders. Her expertise spans microbiome science, probiotics, regulatory strategy, nutrition communication, and scientific advocacy, enabling her to play a pivotal role in shaping the evolving gut health ecosystem in India. She has also contributed extensively to scientific forums and regulatory engagement initiatives, including platforms such as the India Probiotic Symposium, which brings together clinicians, researchers, policymakers, and global experts to strengthen evidence-based dialogue around probiotics and microbiome health. Passionate about bridging the gap between scientific evidence and market claims, Neerja Hajela continues to advocate for responsible healthcare communication, research-driven innovation, and credible scientific practices that support meaningful and sustainable health outcomes in the field of gut health and nutrition.

Content will be updated soon.

Content will be updated soon.

Content will be updated soon.

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Upcoming Webinars

No upcoming webinars at the moment.

Past Webinars